Right now, the US, Europe and Japan are discussing the harmonization of their drug evaluation and certification regulations. If the TFDA and China's State Food and Drug Administration follow their lead and emulate the FDA standards, we will then have the opportunity to open up the cross-strait market and break into the international market.
現在美、歐跟日本都在談藥品審查與認證法規如何一致化，假如台灣的 TFDA 跟大陸的 SFDA 都能朝這方向發展，比照美國 FDA 標準，就有機會打通兩岸、甚至是國際市場。